Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Board Approves Quarterly Dividend

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher announced after the close of market on Tuesday that its board has approved a regular quarterly dividend of $0.02 per share.

The dividend is payable on Oct. 29 to holders of record on Sept. 24.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.